| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5620407 | Revista Colombiana de Cardiología | 2017 | 12 Pages |
Abstract
There are no differences in the use of inotropic drugs, such as dobutamine, levosimendan or milrinone in terms of mortality outcomes. Their use, therefore, will depend on other factors.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Juan M. Sénior, Edison Muñoz, James DÃaz,